Introduction of drug cost analysis system under consideration.

To eliminate a drug price bubble the MOHW mulls an adoption of so called "Drug Cost Analysis" system from coming June, which requires submission of the drug price cost statement at the time of new NHI price registration. Besides, the MOHW also tries to launch a model project of the Reference Price System against 4 to 5 therapeutic groups of drugs. In this way the MOHW intends to save about 200....